Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Nasopharyngeal Carcinoma 6Triple Negative Breast Neoplasms 4Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Lung Neoplasms 2Thoracic Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Radiation Pneumonitis 1Pancreatic Neoplasms 1PD-L1 Positive Non-small Cell Lung Cancer 1Non-squamous Non-small-cell Lung Cancer 1Neoplasms by Site 1Lung Diseases 1Locally Advanced Gastric Cancer 1Esophageal Malignant Neoplasm, Local Recurrence 1Carcinoma, Bronchogenic 1Bronchial Neoplasms 1Breast Neoplasms 1Advanced NSCLC 1Advanced Esophageal Cancer 1

Interventions

Gemcitabine 11Cisplatin 11Radiotherapy, Intensity-Modulated 6tislelizumab 2nimotuzumab 2camrelizumab 2Fluorouracil 2Carboplatin 2spartalizumab 1sintilimab 1sargramostim 1pembrolizumab 1fosaprepitant 1etoposide phosphate 1Tropisetron 1Radiotherapy 1Induction Chemotherapy 1Ifosfamide 1Etoposide 1Docetaxel 1Dexamethasone 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Nasopharyngeal Neoplasms × camrelizumab × Clear all
NCT03427827 2024-04-09

DIPPER

Sun Yat-sen University

Phase 3 Unknown
450 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT04453826 2020-09-28

Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Recruiting
388 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡